ICU Medical Inc
ICUI: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$553.00 | Srx | Jwjnscxq |
ICU Medical Earnings: Operational Problems Continue To Pressure Near-Term Outlook
No-moat ICU Medical turned in a mixed second quarter with weaker-than-expected sales but strong profits. Negatively for 2023, management suggested that sales would be weaker than previously expected in a couple businesses and narrowed its guidance range for profits mildly below our previous expectations. However, making a slight cut to our 2023 view does not materially change our $177 fair value estimate, and we continue to view ICU shares as about fairly valued.